-
???insights.card.a11y.category??? news News
Obesity drug enthusiasm can continue in 2024: Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Mizuho’s Dan Dolev sees more upside for Affirm and SoFi in 2024
-
???insights.card.a11y.category??? news News
Correction needed for some markets, Mizuho’s Ricchiuto says
-
???insights.card.a11y.category??? news News
Market leadership reversal for utilities will continue into 2024, says Mizuho’s Anthony Crowdell
-
???insights.card.a11y.category??? news News
T+1 Accelerated Settlement
-
???insights.card.a11y.category??? news News
Robinhood will benefit from bitcoin ETF, says Mizuho’s Dan Dolev
-
???insights.card.a11y.category??? news News
White House vs. Big Pharma: The battle to lower prices
-
???insights.card.a11y.category??? news News
Vijay Rakesh on Bloomberg Markets: The Close (Starts at 30:50)
-
???insights.card.a11y.category??? news News
GM looks like a ‘buy’ as long-term issues start to get resolved, says Mizuho’s Vijay Rakesh